
Biopsy devices market to be valued at $11.01b by 2030
However, underdeveloped healthcare infrastructures will limit growth.
The global biopsy devices market is projected to reach $11.01b by 2030 at a compound annual growth rate of 7.2%, according to MarketsandMarkets.
The sector’s expansion is attributed to the increasing prevalence of cancer and the growing preference for minimally invasive surgeries.
“Moreover, the improved reimbursement policies are likely to promote the growth of the biopsy device market,” the report said.
However, the underdeveloped healthcare infrastructure in emerging countries is anticipated to challenge the market’s growth.